Due to the increased production of IL-10 in patients with epistaxis, it may be concluded that the up-regulation of IL-10 is a normal immune response to increased expression of IL-17A, performing regulatory functions to modulate tissue damage roles of IL-17A. This evidence concerns the gene IL10 and epistaxis.